• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于需要接受性腺毒性治疗的女性,生育力保存不应仅限于治疗前的冷冻措施,还应考虑治疗后的二次生育力保存及绝经护理管理。

Fertility preservation in females requiring gonadotoxic therapy should be more than freezing measures before therapy - secondary fertility preservation and menopause care management after therapy should also be considered.

作者信息

von Wolff Michael, Imboden Sara, Stute Petra

机构信息

Division of Gynaecological Endocrinology and Reproductive Medicine, University Women's Hospital, Inselspital, Friedbühlstrasse 19, 3010, Bern, Switzerland.

Department of Pelvic Cancer, Unit of Gynecologic Oncology, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Arch Gynecol Obstet. 2025 Jul 12. doi: 10.1007/s00404-025-08104-5.

DOI:10.1007/s00404-025-08104-5
PMID:40650693
Abstract

To date, fertility preservation has mainly been offered to patients prior to gonadotoxic treatment. Ovarian reserve is assessed by analysing blood levels of anti-müllerian hormone (AMH), and gonadal cells or tissue are cryopreserved if indicated and requested by the patient. If primary fertility preservation (Primary FertiProtekt) before gonadotoxic treatment was not performed or was ineffective, secondary fertility preservation should be considered approximately one year after treatment based on a more extensive ovarian reserve analysis including menstrual cycle pattern, antral follicle count, and serum levels of AMH, estradiol and follicle stimulating hormone. Ovarian reserve analysis is also required to consider endocrine treatment in (pre) menopausal patients. Both approaches require the fertility preservation treatment to be tailored to the ovarian reserve status, type of gonadotoxic therapy. For secondary fertility preservation (Secondary FertiProtekt), oocyte freezing may be considered if ovarian reserve is not too low. Monthly treatment cycles, natural cycle or minimal stimulation protocols and follicle aspiration without anesthesia should be preferred. Menopause care management (MenoProtekt) involves acute menopausal symptom relief and prevention of chronic non-communicable diseases. The management needs to be individualized based on type of disease (hormone-dependent or -independent).

摘要

迄今为止,生育力保存主要是在患者接受性腺毒性治疗前提供。通过分析抗苗勒管激素(AMH)的血液水平来评估卵巢储备,如果患者有指征并提出要求,则对性腺细胞或组织进行冷冻保存。如果在性腺毒性治疗前未进行初级生育力保存(初级FertiProtekt)或其无效,则应在治疗后约一年,基于更广泛的卵巢储备分析,包括月经周期模式、窦卵泡计数以及AMH、雌二醇和促卵泡生成素的血清水平,考虑进行次级生育力保存。对于(围)绝经期患者,考虑内分泌治疗时也需要进行卵巢储备分析。这两种方法都要求生育力保存治疗要根据卵巢储备状态、性腺毒性治疗类型进行调整。对于次级生育力保存(次级FertiProtekt),如果卵巢储备不是过低,可以考虑卵母细胞冷冻。应优先选择每月治疗周期、自然周期或最小刺激方案以及无需麻醉的卵泡抽吸。绝经护理管理(MenoProtekt)包括缓解急性绝经症状和预防慢性非传染性疾病。管理需要根据疾病类型(激素依赖性或非依赖性)进行个体化。

相似文献

1
Fertility preservation in females requiring gonadotoxic therapy should be more than freezing measures before therapy - secondary fertility preservation and menopause care management after therapy should also be considered.对于需要接受性腺毒性治疗的女性,生育力保存不应仅限于治疗前的冷冻措施,还应考虑治疗后的二次生育力保存及绝经护理管理。
Arch Gynecol Obstet. 2025 Jul 12. doi: 10.1007/s00404-025-08104-5.
2
Hematologic cancers in women: from fertility preservation to post-cancer fertility outcomes.女性血液系统癌症:从生育力保存到癌症后生育结局
Hum Reprod. 2025 Jul 1;40(7):1315-1324. doi: 10.1093/humrep/deaf071.
3
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).针对接受体外受精加卵胞浆内单精子注射(IVF/ICSI)的女性,使用卵巢储备标志物进行个性化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2.
4
ESHRE good practice recommendations on fertility preservation involving testicular tissue cryopreservation in children receiving gonadotoxic therapies†.欧洲人类生殖与胚胎学会(ESHRE)关于在接受性腺毒性治疗的儿童中进行睾丸组织冷冻保存的生育力保存的良好实践建议† 。
Hum Reprod. 2025 Jun 27. doi: 10.1093/humrep/deaf106.
5
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
6
Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.随机启动卵巢刺激用于在性腺毒性癌症治疗前希望保留生育能力的女性的卵母细胞或胚胎冷冻保存。
Curr Pharm Biotechnol. 2017 Nov 10;18(8):609-613. doi: 10.2174/1389201018666170808122531.
7
Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.自体富血小板血浆卵巢内注射治疗卵巢低反应患者的疗效:系统评价和荟萃分析。
Arch Gynecol Obstet. 2024 Jun;309(6):2323-2338. doi: 10.1007/s00404-024-07442-0. Epub 2024 Apr 8.
8
Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS).用于经前综合征(PMS)的促性腺激素释放激素(GnRH)类似物。
Cochrane Database Syst Rev. 2025 Jun 10;6(6):CD011330. doi: 10.1002/14651858.CD011330.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.早期乳腺癌女性生育力保存中控制性卵巢过度刺激的安全性和有效性:一项系统评价
Hum Reprod. 2017 May 1;32(5):1033-1045. doi: 10.1093/humrep/dex027.

本文引用的文献

1
Safety of ovarian cryopreservation and transplantation in patients with acute leukemia: a case series.卵巢组织冻存和移植治疗急性白血病患者的安全性:病例系列研究。
Am J Obstet Gynecol. 2024 Jan;230(1):79.e1-79.e10. doi: 10.1016/j.ajog.2023.08.032. Epub 2023 Sep 2.
2
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会(ESC)与欧洲血液学协会(EHA)、欧洲治疗放射学与肿瘤学协会(ESTRO)以及国际心脏肿瘤学会(IC-OS)合作制定的心脏肿瘤学指南。
Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):e333-e465. doi: 10.1093/ehjci/jeac106.
3
Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause.瑞士共识:脱氢表雄酮在女性生殖泌尿系统绝经期综合征管理中的作用。
Climacteric. 2022 Jun;25(3):246-256. doi: 10.1080/13697137.2021.2008894. Epub 2021 Dec 15.
4
Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer.早期乳腺癌绝经前和绝经后女性癌症治疗引起的骨质流失(CTIBL)管理的更新指南。
J Bone Oncol. 2021 Mar 18;28:100355. doi: 10.1016/j.jbo.2021.100355. eCollection 2021 Jun.
5
Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers.冷冻卵巢组织移植在 285 名女性中的应用:五个欧洲主要中心的回顾性研究。
Fertil Steril. 2021 May;115(5):1102-1115. doi: 10.1016/j.fertnstert.2021.03.008.
6
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.癌症患者的生育力保存:ASCO 临床实践指南更新。
J Clin Oncol. 2018 Jul 1;36(19):1994-2001. doi: 10.1200/JCO.2018.78.1914. Epub 2018 Apr 5.
7
Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial.使用冷冻保存的卵母细胞进行赠卵计划:一项前瞻性、随机、对照、临床试验。
Hum Reprod. 2010 Sep;25(9):2239-46. doi: 10.1093/humrep/deq146. Epub 2010 Jun 30.
8
Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study.儿童癌症女性幸存者的生育力:来自儿童癌症幸存者研究的报告
J Clin Oncol. 2009 Jun 1;27(16):2677-85. doi: 10.1200/JCO.2008.20.1541. Epub 2009 Apr 13.
9
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.绝经前女性卵巢切除术后的生存模式:一项基于人群的队列研究。
Lancet Oncol. 2006 Oct;7(10):821-8. doi: 10.1016/S1470-2045(06)70869-5.
10
Livebirth after orthotopic transplantation of cryopreserved ovarian tissue.冷冻保存的卵巢组织原位移植后活产
Lancet. 2004;364(9443):1405-10. doi: 10.1016/S0140-6736(04)17222-X.